FS Development Corp II Cl A (FSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FSII | CMPX | CRDF | ||
| Company | FS Development Corp II Cl A | Compass Therapeutics Inc | Cardiff Oncology Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.05 | 1.5000 | 4.01 | ||
| High | 10.16 | 1.5550 | 4.41 | ||
| Low | 9.69 | 1.4400 | 3.96 | ||
| Last | 9.80 | 1.5200 | 4.34 | ||
| Change | -0.20 | +0.0200 | +0.42 | ||
| % Change | -2.00% | +1.33% | +10.71% | ||
| Volume | 289,100 | 337,000 | 1,060,100 | ||
| 20-Day Average Volume | 227,795 | 413,555 | 4,357,265 | ||
| Previous Close | 10.00 | 1.5000 | 3.92 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.86 | 1.5480 | 3.48 | ||
| 20-Day Raw Stochastic | 2.99% | 40.43% | 61.55% | ||
| 20-Day Relative Strength | 38.90% | 48.11% | 59.37% | ||
| Weighted Alpha | -13.88 | -13.49 | +10.45 | ||
| Today's Opinion | 8% Buy | 8% Buy | 72% Buy | ||
| Previous Opinion | 8% Buy | 8% Buy | 72% Buy | ||
| Last Month's Opinion | 72% Buy | 8% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.89% since 12/16/21 | +7.04% since 12/18/24 | -3.34% since 12/18/24 | ||
| Low | 9.64 on 12/21/21 | 1.3300 on 12/19/24 | 3.82 on 12/24/24 | ||
| High | 10.86 on 12/21/21 | 1.5550 on 12/26/24 | 5.00 on 12/19/24 | ||
| 1-Month | |||||
| %Chg | -30.10% since 11/23/21 | +0.66% since 11/26/24 | +76.42% since 11/26/24 | ||
| Low | 9.64 on 12/21/21 | 1.3300 on 12/19/24 | 2.26 on 12/06/24 | ||
| High | 15.00 on 12/01/21 | 1.8000 on 12/11/24 | 5.64 on 12/17/24 | ||
| 3-Month | |||||
| %Chg | -1.90% since 09/23/21 | -16.02% since 09/26/24 | +57.25% since 09/26/24 | ||
| Low | 9.64 on 12/21/21 | 1.2700 on 11/18/24 | 2.26 on 12/06/24 | ||
| High | 15.05 on 11/19/21 | 2.0800 on 10/14/24 | 5.64 on 12/17/24 | ||
| 6-Month | |||||
| %Chg | -0.81% since 06/23/21 | +43.40% since 06/26/24 | +85.47% since 06/26/24 | ||
| Low | 9.64 on 12/21/21 | 0.7650 on 07/05/24 | 2.01 on 08/05/24 | ||
| High | 15.05 on 11/19/21 | 2.0800 on 10/14/24 | 5.64 on 12/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 203,125 | 206,384 | 200,445 | ||
| Shares Outstanding, K | 20,727 | 137,589 | 51,134 | ||
| Annual Sales | 0 | 0 | 490,000 | ||
| Annual Net Income | 0 | -42,490,000 | -41,440,000 | ||
| Last Quarter Sales | 0 | 850,000 | 170,000 | ||
| Last Quarter Net Income | -1,220,000 | -13,080,000 | -11,860,000 | ||
| 60-Month Beta | N/A | 0.89 | 1.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/12/21 | -0.08 on 11/12/24 | -0.25 on 11/07/24 | ||
| Latest Earnings Date | 10/16/12 | 11/14/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||